Get the latest GPCB - Gpc Bitoech AG ADS stock market performance data and financial news.
Get the latest GPCB - Gpc Bitoech AG ADS together with stock market performance data and financial news.
Get the latest GPCB - Gpc Bitoech AG ADS stock market performance data and financial news.
Read Jim Cramer's take on Gpc Bitoech AG ADS (GPCB) and get his latest thoughts on the company?s performance and outlook
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
BladeLogic soars in its public debut.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10370216/1/wednesdays-small-cap-winners-losers.html
Prostate cancer drug satraplatin may not get approved till early 2009, one analyst says.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/newsanalysis/pharmaceuticals/10370129.html
An advisory panel recommends that the agency wait to decide on cancer drug Orplatna.. Check out TheStreet for the latest stock market news and financial investment headlines.
A bungled FDA review crushed the stock, but its prostate drug has huge potential.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10371795/1/dont-give-up-on-spectrum-pharma.html
The biotech withdraws its new-drug application for accelerated approval of the prostate cancer drug.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10371024/1/gpc-biotech-takes-satraplatin-off-fast-track.html
Connect with TheStreet